Works by Bairey, Osnat
Results: 56
CLL-045: Long-Term Follow-up, Up to 7 Years, in the RESONATE-2 Study of First-Line Ibrutinib Treatment for Chronic Lymphocytic Leukemia (CLL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S316, doi. 10.1016/S2152-2650(21)01747-X
- By:
- Publication type:
- Article
Poster: CLL-045: Long-Term Follow-up, Up to 7 Years, in the RESONATE-2 Study of First-Line Ibrutinib Treatment for Chronic Lymphocytic Leukemia (CLL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S221, doi. 10.1016/S2152-2650(21)01393-8
- By:
- Publication type:
- Article
Five-Year Follow-Up After Ibrutinib Therapy for First-Line Treatment of Chronic Lymphocytic Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S274, doi. 10.1016/j.clml.2019.07.205
- By:
- Publication type:
- Article
Phase 3 Study of Ibrutinib versus Chlorambucil in Patients ≥65 Years with Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S45, doi. 10.1016/j.clml.2016.07.065
- By:
- Publication type:
- Article
Analysis of Quality of Life and Well-being from the Randomized Phase 3 Study of Ibrutinib Versus Chlorambucil in Older Patients with Treatment-naïve CLL (RESONATE-2TM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S46, doi. 10.1016/j.clml.2016.07.066
- By:
- Publication type:
- Article
Primary CNS Lymphoma in the Elderly: The Challenge.
- Published in:
- Acta Haematologica, 2019, v. 141, n. 4, p. 138, doi. 10.1159/000495284
- By:
- Publication type:
- Article
Primary CNS Lymphoma in the Elderly: The Challenge.
- Published in:
- Acta Haematologica, 2019, v. 141, n. 3, p. 138, doi. 10.1159/000495284
- By:
- Publication type:
- Article
Limited Positron Emission Tomography-Computed Tomography for Restaging of Lymphoma: A Strategy for Reducing Radiation Exposure among Patients with Early-Stage Curable Lymphoma.
- Published in:
- Acta Haematologica, 2014, v. 131, n. 4, p. 239, doi. 10.1159/000354842
- By:
- Publication type:
- Article
Is Bone Marrow Biopsy Obligatory in All Patients with Non-Hodgkin’s Lymphoma?
- Published in:
- Acta Haematologica, 2007, v. 118, n. 1, p. 61, doi. 10.1159/000102589
- By:
- Publication type:
- Article
Pathogenesis, prevalence, and prognostic significance of cytopenias in chronic lymphocytic leukemia (CLL): a retrospective comparative study of 213 patients from a national CLL database of 1,518 cases.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 5, p. 661, doi. 10.1007/s00277-012-1663-3
- By:
- Publication type:
- Article
Early death in patients diagnosed with non-Hodgkin's lymphoma.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 3, p. 345, doi. 10.1007/s00277-012-1623-y
- By:
- Publication type:
- Article
Cell surface expression of CD25 antigen (surface IL-2 receptor alpha-chain) is not a prognostic marker in chronic lymphocytic leukemia: results of a retrospective study of 281 patients.
- Published in:
- Annals of Hematology, 2012, v. 91, n. 10, p. 1597, doi. 10.1007/s00277-012-1492-4
- By:
- Publication type:
- Article
Presenting features and outcome of chronic lymphocytic leukemia patients diagnosed at age 80 years or more. An ICLLSG study.
- Published in:
- Annals of Hematology, 2011, v. 90, n. 10, p. 1123, doi. 10.1007/s00277-011-1259-3
- By:
- Publication type:
- Article
Consolidation Treatment for Primary Central Nervous System Lymphoma: Which Modality for Whom?
- Published in:
- Acta Haematologica, 2021, v. 144, n. 4, p. 389, doi. 10.1159/000511208
- By:
- Publication type:
- Article
Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET/ CT is beneficial: a prospective multicentre trial of 355 patients.
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 5, p. 709, doi. 10.1111/bjh.14734
- By:
- Publication type:
- Article
The addition of rituximab to anthracycline-based chemotherapy significantly improves outcome in ‘Western’ patients with intravascular large B-cell lymphoma.
- Published in:
- British Journal of Haematology, 2008, v. 143, n. 2, p. 253, doi. 10.1111/j.1365-2141.2008.07338.x
- By:
- Publication type:
- Article
The Utility of <sup>18</sup>F-fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography in Cutaneous B-Cell Lymphoma.
- Published in:
- Israel Medical Association Journal, 2019, v. 21, n. 9, p. 580
- By:
- Publication type:
- Article
Superior prognostic accuracy of FIGO staging system in primary female genital tract lymphomas: A retrospective study (IELSG35).
- Published in:
- Hematological Oncology, 2024, v. 42, n. 6, p. 1, doi. 10.1002/hon.3312
- By:
- Publication type:
- Article
A retrospective study of 222 patients with newly diagnosed primary central nervous system lymphoma—Outcomes indicative for improved survival overtime.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 5, p. 838, doi. 10.1002/hon.3198
- By:
- Publication type:
- Article
Low-dose fludarabine and cyclophosphamide combined with standard dose rituximab (LD-FCR) is an effective and safe regimen for elderly untreated patients with chronic lymphocytic leukemia: The Israeli CLL study group experience.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Persistently low lymphocyte counts after FCR therapy for chronic lymphocytic leukemia are associated with longer overall survival.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Serum albumin level at diagnosis of diffuse large B-cell lymphoma: an important simple prognostic factor.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Characteristics of primary splenic diffuse large B-cell lymphoma and role of splenectomy in improving survival.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 17, p. 2909, doi. 10.1002/cncr.29487
- By:
- Publication type:
- Article
Significance of bone marrow reticulin fibrosis in chronic lymphocytic leukemia at diagnosis: A study of 176 patients with prognostic implications.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Significance of bone marrow reticulin fibrosis in chronic lymphocytic leukemia at diagnosis.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 10, p. 1853, doi. 10.1002/cncr.27930
- By:
- Publication type:
- Article
Mortalin peptides exert antitumor activities and act as adjuvants to antibody-mediated complement-dependent cytotoxicity.
- Published in:
- International Journal of Oncology, 2020, v. 57, n. 4, p. 1013
- By:
- Publication type:
- Article
The risk of bleeding in patients receiving ibrutinib combined with novel direct oral anticoagulants.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 2, p. e31, doi. 10.1111/bjh.16422
- By:
- Publication type:
- Article
Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 6, p. 604, doi. 10.1002/ajh.25766
- By:
- Publication type:
- Article
Characteristics, management and outcome of DLBCL patients, presenting with simultaneous systemic and CNS disease at diagnosis: A retrospective multicenter study.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 9, p. 992, doi. 10.1002/ajh.25558
- By:
- Publication type:
- Article
Single‐agent ibrutinib versus chemoimmunotherapy regimens for treatment‐naïve patients with chronic lymphocytic leukemia: A cross‐trial comparison of phase 3 studies.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 11, p. 1402, doi. 10.1002/ajh.25259
- By:
- Publication type:
- Article
Richter's transformation to diffuse large B-cell lymphoma: A retrospective study reporting clinical data, outcome, and the benefit of adding rituximab to chemotherapy, from the Israeli CLL Study Group.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 11, p. E218, doi. 10.1002/ajh.23826
- By:
- Publication type:
- Article
Survival trends among 1,325 patients with chronic lymphocytic leukemia seen over the past 40 years in Israel.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 12, p. 985, doi. 10.1002/ajh.22160
- By:
- Publication type:
- Article
Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma.
- Published in:
- American Journal of Hematology, 2009, v. 84, n. 6, p. 338, doi. 10.1002/ajh.21406
- By:
- Publication type:
- Article
Clinical severe hepatic venoocclusive disease during induction treatment of acute monoblastic leukemia managed with defibrotide.
- Published in:
- American Journal of Hematology, 2002, v. 69, n. 4, p. 281, doi. 10.1002/ajh.10072
- By:
- Publication type:
- Article
Predictive value of the CLL‐IPI in CLL patients receiving chemo‐immunotherapy as first‐line treatment.
- Published in:
- European Journal of Haematology, 2018, v. 101, n. 5, p. 703, doi. 10.1111/ejh.13149
- By:
- Publication type:
- Article
Outcomes of second‐line treatment after fludarabine cyclophosphamide and rituximab in patients with chronic lymphocytic leukemia outside clinical trials.
- Published in:
- European Journal of Haematology, 2018, v. 101, n. 3, p. 399, doi. 10.1111/ejh.13129
- By:
- Publication type:
- Article
Serum immunoglobulin levels at diagnosis have no prognostic significance in stage A chronic lymphocytic leukemia: a study of 1113 cases from the Israeli CLL Study Group.
- Published in:
- European Journal of Haematology, 2014, v. 93, n. 1, p. 29, doi. 10.1111/ejh.12290
- By:
- Publication type:
- Article
Insect-bite-like reaction in patients with chronic lymphocytic leukemia: a study from the Israeli Chronic Lymphocytic Leukemia Study Group.
- Published in:
- European Journal of Haematology, 2012, v. 89, n. 6, p. 491, doi. 10.1111/ejh.12015
- By:
- Publication type:
- Article
Diagnostic accuracy of PET/CT in patients with extranodal marginal zone MALT lymphoma.
- Published in:
- European Journal of Haematology, 2007, v. 79, n. 3, p. 205, doi. 10.1111/j.1600-0609.2007.00895.x
- By:
- Publication type:
- Article
Antiphospholipid antibodies may be a new prognostic parameter in aggressive non-Hodgkin's lymphoma.
- Published in:
- European Journal of Haematology, 2006, v. 76, n. 5, p. 384, doi. 10.1111/j.1600-0609.2005.00620.x
- By:
- Publication type:
- Article
Severe myelotoxicity of oral etoposide in heavily pretreated patients with non-Hodgkin's lymphoma or chronic lymphatic leukemia.
- Published in:
- Cancer (0008543X), 1996, v. 77, n. 11, p. 2313, doi. 10.1002/(SICI)1097-0142(19960601)77:11<2313::AID-CNCR20>3.0.CO;2-Z
- By:
- Publication type:
- Article
An evaluation of lateral and medial transposition of the ovaries out of radiation fields.
- Published in:
- 1994
- By:
- Publication type:
- journal article
Orbital and adnexal involvement in systemic non-Hodgkin's lymphoma.
- Published in:
- 1994
- By:
- Publication type:
- journal article
Up to 6.5 years (median 4 years) of follow-up of first-line ibrutinib in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma and high-risk genomic features: integrated analysis of two phase 3 studies.
- Published in:
- Leukemia & Lymphoma, 2022, v. 63, n. 6, p. 1375, doi. 10.1080/10428194.2021.2020779
- By:
- Publication type:
- Article
Chlorambucil for the treatment of patients with chronic lymphocytic leukemia (CLL) – a systematic review and meta-analysis of randomized trials.
- Published in:
- Leukemia & Lymphoma, 2016, v. 57, n. 9, p. 2047, doi. 10.3109/10428194.2016.1154956
- By:
- Publication type:
- Article
Abstracts from the 5th International Workshop on Positron Emission Tomography in Lymphoma held in Menton, France, 19-20 September 2014.
- Published in:
- Leukemia & Lymphoma, 2015, v. 56, n. 5, p. 1233, doi. 10.3109/10428194.2015.1034707
- By:
- Publication type:
- Article
Expression of VEGF-C, VEGF-D and their receptor VEGFR-3 in diffuse large B-cell lymphomas.
- Published in:
- Leukemia & Lymphoma, 2007, v. 48, n. 11, p. 2213, doi. 10.1080/10428190701632822
- By:
- Publication type:
- Article
Resveratrol Enhances mRNA and siRNA Lipid Nanoparticles Primary CLL Cell Transfection.
- Published in:
- Pharmaceutics, 2020, v. 12, n. 6, p. 520, doi. 10.3390/pharmaceutics12060520
- By:
- Publication type:
- Article
Role and Prognostic Significance of the Ki-67 Index in Non-Hodgkin's Lymphoma.
- Published in:
- European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 1, p. 1
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG-PET/CT Pulmonary Infiltrates in non-Hodgkin's lymphoma Patients Treated with Combined Immunochemotherapy: Incidence and Clinical Characteristics.
- Published in:
- Israel Medical Association Journal, 2017, v. 19, n. 6, p. 372
- By:
- Publication type:
- Article